https://www.onhealthcare.tech/p/profluents-225b-lilly-deal-and-whyThoughts on Healthcare Markets & Technologyen2026-04-30T00:44:36+00:00Profluent’s $2.25B Lilly Deal and Why Treating Proteins as a Language Modeling Problem Is a Bigger Story Than the Headline Suggests: Scaling Laws, Synthetic Biology, and the Compute Substrate Thesishttps://www.onhealthcare.tech/p/lilly-paid-225b-for-a-company-thatThoughts on Healthcare Markets & Technologyen2026-04-30T00:16:28+00:00Lilly paid $2.25B for a company that treats biology like a language model.https://www.onhealthcare.tech/p/how-ai-value-based-care-bundles-medicareThoughts on Healthcare Markets & Technologyen2026-04-28T22:20:05+00:00How AI, Value Based Care Bundles, Medicare Payment Compression, and IMG-Driven Residency Match Dynamics Will Reshuffle the Wealthiest Physician Specialty Rankings Over the Next Five to Ten Yearshttps://www.onhealthcare.tech/p/when-hims-lost-its-moatThoughts on Healthcare Markets & Technologyen2026-04-28T17:38:44+00:00When $Hims Lost Its Moat